Botulinum Neurotoxins: History, Mechanism, and Applications. A Narrative Review
Journal of Neurochemistry · 2025-08 · 169 (8)
DOI: 10.1111/jnc.70187 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neurochemistry, online erschienen am 05.08.2025. Verfasst von Arik Monash und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Israel Institute for Biological Research (IIBR), Ness Ziona, Israel. Hauptthemen laut MEDLINE: Botulinum Toxins, Neurotoxins. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Israel Science Foundation.
Abstract (Originalsprache)
Botulinum neurotoxins (BoNTs), produced by Clostridium botulinum , exert their potent neuroparalytic effects by specifically targeting presynaptic cholinergic nerve terminals. BoNTs consist of a heavy chain that mediates high‐affinity neuronal binding and endocytosis, and a light chain that, once translocated into the cytosol, acts as a zinc‐dependent metalloprotease. The light chain cleaves SNARE proteins essential for synaptic vesicle fusion, thereby inhibiting acetylcholine release and leading to flaccid paralysis. This intoxication spans foodborne, wound, and infant botulism, all characterized by commonly observed heat‐resistant endospores that enable bacterial survival under adverse conditions. BoNT intoxication induces flaccid paralysis, and both natural and synthetic neurotoxins disrupt neuronal communication by targeting synaptic components. However, BoNTs differ in their origin, mechanism of action, structure, and interactions. Clinical harnessing of non‐poisoning low doses of BoNT/A and BoNT/B serotypes is used for alleviating symptoms of diverse diseases. Molecular engineering and clinical formulation enabled BoNTs optimization into pharmacologically safe and targeted therapeutic agents that replicate the selective neuronal silencing observed in their natural forms. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Israel Institute for Biological Research (IIBR), Ness Ziona, Israel.
- Obesity and Metabolism Laboratory, Faculty of Medicine, Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel.
- Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.
- Department of Infectious Diseases, IIBR, Ness Ziona, Israel.
- The Edmond and Lily Safra Center for Brain Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.
ORCID-Profile: Hermona Soreq
Förderung
- Israel Science Foundation
Zitieren
APA
Monash, A., Tam, J., Rosen, O., & Soreq, H. (2025). Botulinum Neurotoxins: History, Mechanism, and Applications. A Narrative Review. Journal of Neurochemistry, 169(8). https://doi.org/10.1111/jnc.70187
Vancouver
Monash A, Tam J, Rosen O, Soreq H. Botulinum Neurotoxins: History, Mechanism, and Applications. A Narrative Review. Journal of Neurochemistry. 2025;169(8). doi:10.1111/jnc.70187
BibTeX
@article{Monash2025,
author = {Monash, Arik and Tam, Joseph and Rosen, Osnat and Soreq, Hermona},
title = {Botulinum Neurotoxins: History, Mechanism, and Applications. A Narrative Review},
journal = {Journal of Neurochemistry},
year = {2025},
volume = {169},
number = {8},
doi = {10.1111/jnc.70187}
}
EUVIMED